Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts

Alessandra Mangia, Scott Milligan, Mandana Khalili, Stefano Fagiuoli, Stephen D. Shafran, Fabrice Carrat, Denis Ouzan, George Papatheodoridis, Alnoor Ramji, Sergio M. Borgia, Heiner Wedemeyer, Ruggero Losappio, Francisco Pérez‐Hernandez, Nicole Wick, Robert S. Brown, Pietro Lampertico, Karen Doucette, Ioanna Ntalla, Heribert Ramroth, Michael Mertens, Kim Vanstraelen, Juan Turnes

Open source

DOI: 10.1111/liv.14537
Published: 2020-06-09
Container: Liver International
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/liv.14537,
  title = {Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts},
  author = {Alessandra Mangia and Scott Milligan and Mandana Khalili and Stefano Fagiuoli and Stephen D. Shafran and Fabrice Carrat and Denis Ouzan and George Papatheodoridis and Alnoor Ramji and Sergio M. Borgia and Heiner Wedemeyer and Ruggero Losappio and Francisco Pérez‐Hernandez and Nicole Wick and Robert S. Brown and Pietro Lampertico and Karen Doucette and Ioanna Ntalla and Heribert Ramroth and Michael Mertens and Kim Vanstraelen and Juan Turnes},
  year = {2020},
  journal = {Liver International},
  doi = {10.1111/liv.14537},
  url = {https://doi.org/10.1111/liv.14537}
}

RIS

TY  - JOUR
TI  - Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts
AU  - Alessandra Mangia
AU  - Scott Milligan
AU  - Mandana Khalili
AU  - Stefano Fagiuoli
AU  - Stephen D. Shafran
AU  - Fabrice Carrat
AU  - Denis Ouzan
AU  - George Papatheodoridis
AU  - Alnoor Ramji
AU  - Sergio M. Borgia
AU  - Heiner Wedemeyer
AU  - Ruggero Losappio
AU  - Francisco Pérez‐Hernandez
AU  - Nicole Wick
AU  - Robert S. Brown
AU  - Pietro Lampertico
AU  - Karen Doucette
AU  - Ioanna Ntalla
AU  - Heribert Ramroth
AU  - Michael Mertens
AU  - Kim Vanstraelen
AU  - Juan Turnes
PY  - 2020
JO  - Liver International
DO  - 10.1111/liv.14537
UR  - https://doi.org/10.1111/liv.14537
ER  -

APA

Mangia, A., Milligan, S., Khalili, M., Fagiuoli, S., Shafran, S. D., Carrat, F., Ouzan, D., Papatheodoridis, G., Ramji, A., Borgia, S. M., Wedemeyer, H., Losappio, R., Pérez‐Hernandez, F., Wick, N., Brown, R. S., Lampertico, P., Doucette, K., Ntalla, I., Ramroth, H., Mertens, M., Vanstraelen, K., & Turnes, J. (2020). Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts. Liver International. https://doi.org/10.1111/liv.14537

Source records

crossref · retrieved 2026-09-27T04:24:37.402Z